TITLE

Pemirolast for Allergic Conjunctivitis

AUTHOR(S)
Preboth, Monica
PUB. DATE
October 2000
SOURCE
American Family Physician;10/1/2000, Vol. 62 Issue 7, p1707
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the approval of pemirolast potassium ophthalmic solution 0.1 percent, a new ocular allergy medication indicated for the prevention of itching associated with allergic conjunctivitis, by the United States Food and Drug Administration. Description of pemirolast; How the drug performed in clinical studies.
ACCESSION #
12470486

Tags: CONJUNCTIVITIS;  EYE -- Inflammation;  ALLERGY

 

Related Articles

  • Effective ocular allergy treatments are dual action. Torkildsen, Gail // Ophthalmology Times;4/1/2006, Vol. 31 Issue 7, p16 

    The article talks about the effective treatment of allergic conjunctivities. The anti-allergy dual-action agents have provided immediate, long-lasting relief from the signs and symptoms of allergic conjunctivitis. Signs and symptoms of common types of allergic conjunctivities include itching,...

  • The Common Manifestations of Ocular Allergy.  // Review of Optometry;4/15/2005, Vol. 142 Issue 4, p32 

    Presents common manifestations of ocular allergy. Seasonal and Perennial Allergic Conjunctivitis; Vernal Keratoconjunctivitis; Atopic Keratoconjunctivitis.

  • Corticosteroid provides potent, safe ocular allergy control. Devgan, Uday; Slonim, Charles B. // Ophthalmology Times;4/1/2006, Vol. 31 Issue 7, p24 

    The article indicates that loteprednol etabonate is a valuable therapeutic option for both short-and- longer-term management of allergic conjunctivitis. The efficacy of loteprednol etabonate for providing rapid and sustained control of allergic signs and symptoms in patients with seasonal...

  • Agent's activity profile targets ocular allergy symptoms. Rosenwasser, Lanny J. // Ophthalmology Times;4/1/2006, Vol. 31 Issue 7, p26 

    The article presents comparative studies which show that Olopatadine HCI offers a unique pharmacologic profile of activity that corresponds to its unsurpassed efficacy in the management of allergic conjunctivitis. Preclinical studies reveal that olopatadine has some unique effects on...

  • Allergic conjunctivitis. Kopes-Kerr, Colin P.; Alper, Brian S. // Cortlandt Forum;Feb2007, Vol. 20 Issue 2, p65 

    The article offers information about allergic conjunctivitis. It is an ocular itching or burning, associated with weeping, allergic history and other allergic symptoms. It is caused by inhalants, allergens, history of allergic disease, seasonal allergies and sensitivity to airborne allergens....

  • ACUTE ALLERGIC CONJUNCTIVITIS.  // Review of Optometry;3/15/2004 Supplement, Vol. 141, p17A 

    The article presents information on acute allergic conjunctivitis (AAC). AAC describes the abrupt and immediate response seen in sensitized individuals after exposure to a particular allergen or sensitizing agent. Two forms are recognized: seasonal allergic conjunctivitis, which coincides with...

  • What Makes a Patient Allergic? Abelson, Mark B. // Review of Ophthalmology;Mar2005, Vol. 12 Issue 3, p74 

    Examines the factors that can cause allergy in cataract surgery patients. Mechanisms of allergy; Pathogenesis of allergic conjunctivitis; Environmental factors that can cause allergy; Reasons why allergy is more prevalent in industrialized countries; Treatment options for allergies.

  • Allergy Rates with a Fixed Combination. Motolko, Michael A. // Review of Ophthalmology;Oct2008, Vol. 15 Issue 10, p36 

    The article examines the result of a study on allergy rates in a fixed combination therapy. The fixed combination brimonidine 0.3% timolol 0.5% was associated with a 50 percent lower incidence of allergic conjunctivitis than brimonidine monotherapy, according to a study published in September...

  • UPDATE ON OCULAR ALLERGIES IN ADULTS. Raizman, Michael B. // Ophthalmology Times;5/1/2007 New Paradigms in the Treat, Vol. 32, p5 

    The article provides information on topics related to ocular allergies in adults. Seasonal allergic conjunctivitis (SAC) is caused by exposure to airborne pollens from grasses, hay, weeds, and trees. Based on the history and clinical findings, the diagnosis of SAC is usually straightforward ....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics